FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernhard Wörmann

Research Profile

Procedures

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Bernhard Wörmann; Mathias Freund; Friedrich Overkamp; Gerhard Ehninger
[Status of clinical trials in oncology--2013 and onwards].
Eva Lengfelder; Carsten Müller-Tidow; Cristina Sauerland; Stephanie Schneider; Susanne Schnittger; Beate Schultheis; Hubert Serve; Karsten Spiekermann; Bernhard Wörmann; Carlo Aul; Wolfgang E Berdel; Jan Braess; Thomas Büchner; Philipp Erben; Claudia Haferlach; Torsten Haferlach; Benjamin Hanfstein; Rüdiger Hehlmann; Achim Heinecke; Wolfgang Hiddemann; Wolf-Karsten Hofmann; Heinz A Horst; Karl-Anton Kreuzer; Utz Krug
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Annika Dufour; Wolfgang Hiddemann; Eva Hoster; Purvi M Kakadia; Bianka Ksienzyk; Maria Cristina Sauerland; Friederike Schneider; Stephanie Schneider; Karsten Spiekermann; Marion Subklewe; Bernhard Wörmann; Tobias Benthaus; Wolfgang E Berdel; Stefan K Bohlander; Jan Braess; Thomas Büchner
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernhard Wörmann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bernhard Wörmann; Mathias Freund; Friedrich Overkamp; Gerhard Ehninger
[Status of clinical trials in oncology--2013 and onwards].
Onkologie 2013;36 Suppl 2():3-8.
2013: Eva Lengfelder; Carsten Müller-Tidow; Cristina Sauerland; Stephanie Schneider; Susanne Schnittger; Beate Schultheis; Hubert Serve; Karsten Spiekermann; Bernhard Wörmann; Carlo Aul; Wolfgang E Berdel; Jan Braess; Thomas Büchner; Philipp Erben; Claudia Haferlach; Torsten Haferlach; Benjamin Hanfstein; Rüdiger Hehlmann; Achim Heinecke; Wolfgang Hiddemann; Wolf-Karsten Hofmann; Heinz A Horst; Karl-Anton Kreuzer; Utz Krug
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Annals of hematology 2013;92(1):41-52.
2012: Annika Dufour; Wolfgang Hiddemann; Eva Hoster; Purvi M Kakadia; Bianka Ksienzyk; Maria Cristina Sauerland; Friederike Schneider; Stephanie Schneider; Karsten Spiekermann; Marion Subklewe; Bernhard Wörmann; Tobias Benthaus; Wolfgang E Berdel; Stefan K Bohlander; Jan Braess; Thomas Büchner
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.
Annals of hematology 2012;91(7):1051-63.
2012: Bernhard Wörmann
[Foreword].
Onkologie 2012;35 Suppl 5():2.
2010: Utz Krug; Christoph Röllig; Anja Koschmieder; Achim Heinecke; Maria Cristina Sauerland; Markus Schaich; Christian Thiede; Michael Kramer; Jan Braess; Karsten Spiekermann; Torsten Haferlach; Claudia Haferlach; Steffen Koschmieder; Christian Rohde; Hubert Serve; Bernhard Wörmann; Wolfgang Hiddemann; Gerhard Ehninger; Wolfgang E Berdel; Thomas Büchner; Carsten Müller-Tidow
Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Lancet 2010;376(9757):2000-8.
2010: Henk S P Garritsen; Lars Macke; Wilhelm Meyring; Horst Hannig; Ute Pägelow; Bernhard Wörmann; Robert Geffers; Kurt E J Dittmar; Werner Lindenmaier
Efficient generation of clinical-grade genetically modified dendritic cells for presentation of multiple tumor-associated proteins.
Transfusion 2010;50(4):831-42.
2010: Lars Macke; Henk S P Garritsen; Wilhelm Meyring; Horst Hannig; Ute Pägelow; Bernhard Wörmann; Christoph Piechaczek; Robert Geffers; Manfred Rohde; Werner Lindenmaier; Kurt E J Dittmar
Evaluating maturation and genetic modification of human dendritic cells in a new polyolefin cell culture bag system.
Transfusion 2010;50(4):843-55.
2010: Annika Dufour; Friederike Schneider; Klaus Metzeler; Eva Hoster; Stephanie Schneider; Evelyn Zellmeier; Tobias Benthaus; Maria Cristina Sauerland; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Jan Braess; Wolfgang Hiddemann; Stefan K Bohlander; Karsten Spiekermann
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):570-7.
2009: Eva Lengfelder; Claudia Haferlach; Susanne Saussele; Torsten Haferlach; Beate Schultheis; S Schnittger; Wolf-Dieter Ludwig; Peter Staib; Carlo Aul; A Grüneisen; W Kern; A Reichle; Hubert Serve; Wolfgang E Berdel; J Braess; K Spiekermann; Bernhard Wörmann; Maria Cristina Sauerland; Achim Heinecke; Wolfgang Hiddemann; Rüdiger Hehlmann; Thomas Büchner
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
Leukemia 2009;23(12):2248-58.
2009: Klaus Metzeler; Annika Dufour; Tobias Benthaus; Manuela Hummel; Maria Cristina Sauerland; Achim Heinecke; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Ulrich Mansmann; Jan Braess; Karsten Spiekermann; Wolfgang Hiddemann; Christian Buske; Stefan K Bohlander
ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):5031-8.
2009: Julie Schanz; Heike Jung; Bernhard Wörmann; Winfried Gassmann; Thomas Petersen; Axel Hinke; Detlef Haase
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes.
Leukemia research 2009;33(9):1183-8.
2009: Jan Braess; Karsten Spiekermann; Peter Staib; Andreas Grüneisen; Bernhard Wörmann; Wolf-Dieter Ludwig; Hubert Serve; Albrecht Reichle; Rudolf Peceny; Daniel Oruzio; Christoph Schmid; Xaver Schiel; Marcus Hentrich; Christina Sauerland; Michael Unterhalt; Michael Fiegl; Wolfgang Kern; Christian Buske; Stefan Bohlander; Achim Heinecke; Herrad Baurmann; Dietrich W Beelen; Wolfgang E Berdel; Thomas Büchner; Wolfgang Hiddemann
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.
Blood 2009;113(17):3903-10.
2009: Annina Herrmann; Eva Hoster; Thomas Zwingers; Günter Brittinger; Marianne Engelhard; Peter Meusers; Marcel Reiser; Roswitha Forstpointner; Bernd Metzner; Norma Peter; Bernhard Wörmann; Lorenz Trümper; Michael Pfreundschuh; Hermann Einsele; Wolfgang Hiddemann; Michael Unterhalt; Martin Dreyling
Improvement of overall survival in advanced stage mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(4):511-8.
2009: Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):61-9.
2008: Klaus Metzeler; Manuela Hummel; Clara D Bloomfield; Karsten Spiekermann; Jan Braess; Maria-Cristina Sauerland; Achim Heinecke; Michael Radmacher; Guido Marcucci; Susan P Whitman; Kati Maharry; Peter Paschka; Richard A Larson; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Ulrich Mansmann; Wolfgang Hiddemann; Stefan K Bohlander; Christian Buske
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.
Blood 2008;112(10):4193-201.
2008: Eva Hoster; Martin Dreyling; Wolfram Klapper; Christian Gisselbrecht; Achiel Van Hoof; Hanneke C Kluin-Nelemans; Michael Pfreundschuh; Marcel Reiser; Bernd Metzner; Hermann Einsele; Norma Peter; Wolfram Jung; Bernhard Wörmann; Wolf-Dieter Ludwig; Ulrich Dührsen; Hartmut Eimermacher; Hannes Wandt; Joerg Hasford; Wolfgang Hiddemann; Michael Unterhalt
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma.
Blood 2008;111(2):558-65.
2007: Thomas Büchner; Utz Krug; Wolfgang E Berdel; Achim Heinecke; Maria Cristina Sauerland; Bernhard Wörmann; Wolfgang Hiddemann
Maintenance for acute myeloid leukemia revisited.
Current treatment options in oncology 2007;8(4):296-304.
2007: Susanne Fritsch; Christian Buske; Bernhard Wörmann; Ulrich Wedding; Wolfgang Hiddemann; Karsten Spiekermann
[Therapy of acute myeloid leukemia (AML) for medically non-fit patients].
Medizinische Klinik (Munich, Germany : 1983) 2007;102(4):324-9.
2006: Thomas Büchner; Wolfgang E Berdel; Claudia Schoch; Torsten Haferlach; Hubert Serve; Joachim Kienast; Susanne Schnittger; Wolfgang Kern; Joëlle Tchinda; Albrecht Reichle; Eva Lengfelder; Peter Staib; Wolf-Dieter Ludwig; Carlo Aul; Hartmut Eimermacher; Leopold Balleisen; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2480-9.
2005: Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood 2005;106(12):3725-32.
2005: Thomas Büchner; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Torsten Haferlach; Susanne Schnittger; Wolfgang Kern; Carlo Aul; Eva Lengfelder; Andrea Schumacher; Albrecht Reichle; Peter Staib; Leopold Balleisen; Hartmut Eimermacher; Andreas Grüneisen; Herbert Rasche; Maria Cristina Sauerland; Achim Heinecke; Rolf M Mesters; Hubert Serve; Joachim Kienast; Wolfgang Hiddemann
Treatment of older patients with AML.
Critical reviews in oncology/hematology 2005;56(2):247-59.
2005: Wolfgang Hiddemann; Karsten Spiekermann; Christian Buske; Michaela Feuring-Buske; Jan Braess; Torsten Haferlach; Claudia Schoch; Wolfgang Kern; Susanne Schnittger; Wolfgang E Berdel; Bernhard Wörmann; Achim Heinecke; Cristina Sauerland; Thomas Büchner
Towards a pathogenesis-oriented therapy of acute myeloid leukemia.
Critical reviews in oncology/hematology 2005;56(2):235-45.
2005: Frank Griesinger; Heike Hennig; Frauke Hillmer; Martina Podleschny; Rainer Steffens; Andreas Pies; Bernhard Wörmann; Detlef Haase; Stefan K Bohlander
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.
Genes, chromosomes & cancer 2005;44(3):329-33.
2005: Georg Lenz; Martin Dreyling; Eva Hoster; Bernhard Wörmann; Ulrich Dührsen; Bernd Metzner; Hartmut Eimermacher; Andreas Neubauer; Hannes Wandt; Hjalmar Steinhauer; Sonja Martin; Else Heidemann; Ali Aldaoud; Reza Parwaresch; Joerg Hasford; Michael Unterhalt; Wolfgang Hiddemann
Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1984-92.
2004: Walter Verbeek; Hans-Jürgen Schulten; Matthias Sperling; Jens Tiesmeier; hans stoop; Winand N M Dinjens; Leendert H J Looijenga; Bernhard Wörmann; László Füzesi; Konrad Donhuijsen
Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.
Human pathology 2004;35(11):1427-30.
2004: Joachim Kienast; Matthias Stelljes; Bjorna Berning; Matthias Kröger; Maria Cristina Sauerland; Achim Heinecke; Claudia Schoch; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel
Transplantation strategies in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S136-7.
2004: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Carlo Aul; Eva Lengfelder; Rüdiger Hehlmann; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Hartmut Eimermacher; Norbert Frickhofen; Joachim Kienast; A Giagounidis; Maria Cristina Sauerland; Achim Heinecke
Subgroup specific therapy effects in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S100-1.
2004: W Kern; Torsten Haferlach; Claudia Schoch; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang E Berdel; Thomas Büchner; Wolfgang Hiddemann
Risk-adapted therapy of AML: the AMLCG experience.
Annals of hematology 2004;83 Suppl 1():S49-51.
2003: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Carlo Aul; Andreas Gruneisen; Eva Lengfelder; Norbert Frickhofen; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Maria Cristina Sauerland; Achim Heinecke
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4496-504.
2003: Torsten Haferlach; Claudia Schoch; Helmut Löffler; Winfried Gassmann; Wolfgang Kern; Susanne Schnittger; Christa Fonatsch; Wolf-Dieter Ludwig; Christian Wuchter; Brigitte Schlegelberger; Peter Staib; Albrecht Reichle; Uschi Kubica; Hartmut Eimermacher; Leopold Balleisen; Andreas Grüneisen; Detlef Haase; Carlo Aul; Jochen Karow; Eva Lengfelder; Bernhard Wörmann; Achim Heinecke; Maria Cristina Sauerland; Thomas Büchner; Wolfgang Hiddemann
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):256-65.
2002: M Faulhaber; Bernhard Wörmann; Arnold Ganser; Walter Verbeek
In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF).
Annals of hematology 2002;81(12):695-700.
2002: Marcel Ott; Heinz Schmidberger; Bernhard Wörmann; Clemens F Albrecht; Olivier Pradier; Clemens F Hess
Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2002;178(5):245-51.
2002: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Helmut Löffler; Torsten Haferlach; Andrea Schumacher; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Herbert Rasche; Carlo Aul; Axel Heyll; Eva Lengfelder; Wolf-Dieter Ludwig; Georg Maschmeyer; Hartmut Eimermacher; Jochen Karow; Norbert Frickhofen; Wolf-Dietrich Hirschmann; Maria Cristina Sauerland
Acute myeloid leukemia: treatment over 60.
Reviews in clinical and experimental hematology 2002;6(1):46-59; discussion 86-7.
2002: Detlef Haase; Claudia Binder; Jürgen Bünger; Christa Fonatsch; Berthold Streubel; Susanne Schnittger; Frank Griesinger; Götz Westphal; Claudia Schoch; Agnes Knopp; Dinko Berkovicz; Otto Krieger; Bernhard Wörmann; Reinhard Hilgers; Ernst Hallier; Thomas Schulz
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.
Leukemia research 2002;26(3):249-54.
2002: Thomas M Behr; Frank Griesinger; Joachim Riggert; Stefan Gratz; Martin Béhé; Cornelia C Kaufmann; Bernhard Wörmann; Günter Brittinger; Wolfgang Becker
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.
Cancer 2002;94(4 Suppl):1363-72.
2001: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Helmut Löffler; Claudia Schoch; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; R Andreesen; Leopold Balleisen; Detlef Haase; Hartmut Eimermacher; Carlo Aul; Herbert Rasche; J Uhlig; Andreas Grüneisen; H E Reis; J Hartlapp; Wolf-Dietrich Hirschmann; H J Weh; H J Pielken; Winfried Gassmann; Maria Cristina Sauerland; Achim Heinecke
Remission induction therapy: the more intensive the better?
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S41-4.
2001: G Jahns-Streubel; Jan Braess; Claudia Schoch; C Fonatsch; Detlef Haase; C Binder; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF.
Leukemia 2001;15(3):377-84.
2001: A Yilmaz; Cornelia C Kaufmann; Claudia Binder; Bernhard Wörmann; Detlef Haase
Effects of amifostine in a patient with an advanced-stage myelodysplastic syndrome.
Annals of hematology 2001;80(1):53-7.
2000: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Wolf-Dieter Ludwig; Claudia Schoch; Torsten Haferlach; Georg Maschmeyer; Peter Staib; Carlo Aul; G A Heyll; Andreas Grüneisen; Herbert Rasche; J H Eimermacher; Leopold Balleisen; H J Pielken; H E Reis; Frank Griesinger; Albrecht Reichle; Maria Cristina Sauerland; Achim Heinecke
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?
International journal of hematology 2000;72(3):285-9.
2000: Eva Lengfelder; Anja Reichert; Claudia Schoch; Detlef Haase; Torsten Haferlach; Helmut Löffler; Peter Staib; Axel Heyll; Wolfgang Seifarth; Susanne Saussele; Christa Fonatsch; Winfried Gassmann; Wolf-Dieter Ludwig; Andreas Hochhaus; D Beelen; Carlo Aul; Maria Cristina Sauerland; Achim Heinecke; Rüdiger Hehlmann; Bernhard Wörmann; Wolfgang Hiddemann; Thomas Büchner
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.
Leukemia 2000;14(8):1362-70.
2000: Susanne Schnittger; U Kinkelin; Claudia Schoch; Achim Heinecke; Detlef Haase; Torsten Haferlach; Thomas Büchner; Bernhard Wörmann; Wolfgang Hiddemann; Frank Griesinger
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML.
Leukemia 2000;14(5):796-804.
1999: G Beyer-Sehlmeyer; Wolfgang Hiddemann; Bernhard Wörmann; Jasmin Bertram
Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.
European journal of cancer (Oxford, England : 1990) 1999;35(12):1735-42.
1999: Wolfgang Hiddemann; W Kern; Claudia Schoch; C Fonatsch; A Heinecke; Bernhard Wörmann; Thomas Büchner
Management of acute myeloid leukemia in elderly patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3569-76.
1999: Kristian Reich; U Brinck; M Letschert; Volker Blaschke; K Dames; Jan Braess; Bernhard Wörmann; Thomas M. Ruenger; Christine Neumann
Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus.
The British journal of dermatology 1999;141(4):739-46.
1999: Thomas M Behr; Bernhard Wörmann; Martin Gramatzki; Joachim Riggert; Stefan Gratz; Martin Béhé; Frank Griesinger; Robert M Sharkey; H J Kolb; Wolfgang Hiddemann; David M Goldenberg; Wolfgang Becker
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3304s-3314s.
1999: Thomas M Behr; A L Salib; Torsten Liersch; Martin Béhé; Christa Angerstein; Rosalyn D Blumenthal; Afshin Fayyazi; Robert M Sharkey; B Ringe; Heinz Becker; Bernhard Wörmann; Wolfgang Hiddemann; David M Goldenberg; Wolfgang Becker
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3232s-3242s.
1999: Andreas Humpe; Joachim Riggert; U Munzel; L M Repas-Humpe; Katalin Vehmeyer; E Brunner; Bernhard Wörmann; Michael Köhler
A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment.
Transfusion 1999;39(10):1120-7.
1999: W Kern; Claudia Schoch; C Fonatsch; A Heinecke; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
[The therapy of acute myeloid leukemia in patients of advanced age].
Deutsche medizinische Wochenschrift (1946) 1999;124(34-35):1005-14.
1999: Thomas M Behr; S Memtsoudis; Vassilios I Vougioukas; Torsten Liersch; Stefan Gratz; F Schmidt; T Lorf; Stefan Post; Bernhard Wörmann; Wolfgang Hiddemann; B Ringe; Wolfgang Becker
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
Anticancer research 1999;19(4A):2427-32.
1999: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Winfried Gassmann; Torsten Haferlach; Christa Fonatsch; Detlef Haase; Claudia Schoch; Dieter K Hossfeld; Eva Lengfelder; Carlo Aul; Axel Heyll; Georg Maschmeyer; Wolf-Dieter Ludwig; Maria Cristina Sauerland; Achim Heinecke
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.
Blood 1999;93(12):4116-24.
1999: B Gahn; B Wendenburg; C Troff; J Neef; D Grove; Torsten Haferlach; Wolfgang Hiddemann; Bernhard Wörmann
Analysis of progenitor cell involvement in B-CLL by simultaneous immunophenotypic and genotypic analysis at the single cell level.
British journal of haematology 1999;105(4):955-9.
1999: Frank Griesinger; M Pirò-Noack; N Kaib; M Falk; A Renziehausen; C Troff; D Grove; Susanne Schnittger; Thomas Büchner; J Ritter; Wolfgang Hiddemann; Bernhard Wörmann
Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: detection in remission marrow predicts outcome.
British journal of haematology 1999;105(1):241-55.
1999: Michaela Feuring-Buske; Detlef Haase; Christian Buske; Wolfgang Hiddemann; Bernhard Wörmann
Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.
Leukemia 1999;13(3):386-92.
1999: Walter Verbeek; Bernhard Wörmann; P Koch; Carlo Aul; H F Hinrichs; Leopold Balleisen; J M Rowe; J Bennett; Detlef Haase; Christa Fonatsch; Achim Heinecke; Thomas Büchner; Wolfgang Hiddemann
Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes.
Journal of cancer research and clinical oncology 1999;125(6):369-74.
1998: Bernhard Wörmann
[High dose therapy with stem cell transplantation].
Der Internist 1998;39(11):1115-22.
1998: Christian Buske; D Becker; Michaela Feuring-Buske; Horst Hannig; Frank Griesinger; Wolfgang Hiddemann; Bernhard Wörmann
TGF-beta and its receptor complex in leukemic B-cell precursors.
Experimental hematology 1998;26(12):1155-61.
1998: Bernhard Herse; Harald Dalichau; Bernhard Wörmann; B Hemmerlein; H Schmidberger; C F Hess; P Hannemann; CP Criée; W Hiddemann; Frank Griesinger
Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
The Thoracic and cardiovascular surgeon 1998;46(5):298-302.
1998: Wolfgang Kern; Jan Braess; A Grote-Metke; H Kuse; R Fuchs; Dieter K Hossfeld; Albrecht Reichle; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group.
Leukemia 1998;12(10):1522-6.
1998: Wolfgang Kern; Carlo Aul; Georg Maschmeyer; R Kuse; A Kerkhoff; A Grote-Metke; Hartmut Eimermacher; Uschi Kubica; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.
Annals of hematology 1998;77(3):115-22.
1998: Susanne Schnittger; Bernhard Wörmann; Wolfgang Hiddemann; Frank Griesinger
Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors.
Blood 1998;92(5):1728-34.
1998: Wolfgang Kern; G Behre; T Rudolf; A Kerkhoff; A Grote-Metke; Hartmut Eimermacher; Uschi Kubica; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Cancer 1998;83(2):291-301.
1998: Wolfgang Kern; Carlo Aul; Georg Maschmeyer; R Schönrock-Nabulsi; Wolf-Dieter Ludwig; A Bartholomäus; P Bettelheim; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison.
Leukemia 1998;12(7):1049-55.
1998: Martin Dreyling; K Schrader; Christa Fonatsch; Brigitte Schlegelberger; Detlef Haase; Claudia Schoch; W Ludwig; Helmut Löffler; Thomas Büchner; Bernhard Wörmann; Wolfgang Hiddemann; Stefan K Bohlander
MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.
Blood 1998;91(12):4662-7.
1998: T Meyer; C Mayer; D Haase; Bernhard Hemmerlein; Bernhard Wörmann
[Primary pulmonary plasmacytoma. Case report of a rare lung tumor].
Deutsche medizinische Wochenschrift (1946) 1998;123(23):730-4.
1998: Bernhard Wörmann; Christian Buske; Wolfgang Hiddemann
[Systemic therapy of low malignancy non-Hodgkin lymphomas].
Praxis 1998;87(23):806-11.
1998: Gerald G Wulf; G Jahns-Streubel; Bernhard Hemmerlein; K Bonnekessen; Bernhard Wörmann; Wolfgang Hiddemann
Plasmacytosis in acute myeloid leukemia: two cases of plasmacytosis and increased IL-6 production in the AML blast cells.
Annals of hematology 1998;76(6):273-7.
1998: Wolfgang Hiddemann; G Jahns-Streubel; Walter Verbeek; Bernhard Wörmann; Detlef Haase; Claudia Schoch
Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities.
Leukemia research 1998;22 Suppl 1():S23-6.
1998: Bernhard Wörmann; H Meden; Joachim Riggert; Andreas Humpe; Gerald Wulf; B Koch; Michael Köhler; Walther Kuhn; Wolfgang Hiddemann
Early intensive and myeloablative adjuvant chemotherapy in women with high-risk breast cancer.
Anticancer research 1998;18(3C):2237-41.
1998: Bernhard Wörmann; G Wulf; Wolfgang Hiddemann
[Clinical studies in oncology. Relevance, design, ethical considerations].
Medizinische Klinik (Munich, Germany : 1983) 1998;93(3):181-9.
1998: Dirk Reinhardt; Detlef Haase; Claudia Schoch; S Wollenweber; E Hinkelmann; W v Heyden; G Lentini; Bernhard Wörmann; W Schröter; Arnulf Pekrun
Hemoglobin F in myelodysplastic syndrome.
Annals of hematology 1998;76(3-4):135-8.
1998: Gerald G Wulf; G Jahns-Streubel; R Nobiling; Frank Strutz; Bernhard Hemmerlein; Wolfgang Hiddemann; Bernhard Wörmann
Renin in acute myeloid leukaemia blasts.
British journal of haematology 1998;100(2):335-7.
1998: Torsten Liersch; W Gatzemeier; P Scharnberg; B Jürgens; Bernhard Wörmann; Heinz Becker; HF Rauschecker; Wolfgang Hiddemann; Gerald G Wulf
[Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1998;115(Suppl I):277-80.
1998: Katalin Vehmeyer; T Hajto; Katarina Hostanska; S Könemann; H Löser; Reinhard Saller; Bernhard Wörmann
Lectin-induced increase in clonogenic growth of haematopoietic progenitor cells.
European journal of haematology 1998;60(1):16-20.
1997: Claudia Schoch; Detlef Haase; Christa Fonatsch; Torsten Haferlach; Helmut Löffler; Brigitte Schlegelberger; Dieter K Hossfeld; R Becher; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group.
British journal of haematology 1997;99(3):605-11.
1997: Bernhard Wörmann; Gerald G Wulf; Frank Griesinger; Wolfgang Hiddemann
[Sensitive detection of disseminated tumor cells--prognostic significance and therapeutic approaches].
Der Internist 1997;38(11):1083-91.
1997: Jan Braess; Kristian Reich; S Willert; F Strutz; Christine Neumann; Wolfgang Hiddemann; Bernhard Wörmann
Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL).
Annals of hematology 1997;75(5-6):227-30.
1997: Christian Buske; A Twiling; G Gogowski; K Schreiber; Michaela Feuring-Buske; Gerald G Wulf; Wolfgang Hiddemann; Bernhard Wörmann
In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
Leukemia 1997;11(11):1862-7.
1997: Andreas Humpe; Joachim Riggert; Katalin Vehmeyer; C Troff; Wolfgang Hiddemann; Michael Köhler; Bernhard Wörmann
Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy.
Transfusion 1997;37(10):1050-7.
1997: G Jahns-Streubel; C Reuter; U Auf der Landwehr; Michael Unterhalt; Eberhard Schleyer; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemia.
Blood 1997;90(5):1968-76.
1997: Oliver Micke; Ulrich Schäfer; Bernhard Wörmann; Wolfgang Hiddemann; Normann Willich
Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.
Anticancer research 1997;17(4B):3007-10.
1997: B Gahn; C Schäfer; J Neef; C Troff; Michaela Feuring-Buske; Wolfgang Hiddemann; Bernhard Wörmann
Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.
Blood 1997;89(12):4275-81.
1997: Walter Verbeek; Detlef Haase; Claudia Schoch; Wolfgang Hiddemann; Bernhard Wörmann
Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen.
Annals of hematology 1997;74(6):275-7.
1997: Karsten Spiekermann; Bernhard Wörmann; KW Rumpf; Wolfgang Hiddemann
Combination chemotherapy with CHOP for recurrent thrombotic thrombocytopenic purpura.
British journal of haematology 1997;97(3):544-6.
1997: Walter Verbeek; Bernhard Wörmann; P Koch; Carlo Aul; H Hinrichs; Leopold Balleisen; J M Rowe; J Bennett; Thomas Büchner; Wolfgang Hiddemann
S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes.
Annals of hematology 1997;74(5):205-8.
1997: Detlef Haase; Michaela Feuring-Buske; C Schäfer; Claudia Schoch; C Troff; B Gahn; Wolfgang Hiddemann; Bernhard Wörmann
Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Leukemia 1997;11(5):674-9.
1997: Christian Buske; G Gogowski; K Schreiber; Margret Rave-Fränk; Wolfgang Hiddemann; Bernhard Wörmann
Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Experimental hematology 1997;25(4):329-37.
1997: C Reuter; Eberhard Schleyer; C Rolf; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
Leukemia 1997;11(4):561-71.
1997: Christian Buske; D Becker; Michaela Feuring-Buske; Horst Hannig; G Wulf; C Schäfer; Wolfgang Hiddemann; Bernhard Wörmann
TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors.
Leukemia 1997;11(3):386-92.
1997: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Michael Zühlsdorf; R Rottmann; G Innig; G Maschmeier; Wolf-Dieter Ludwig; Maria Cristina Sauerland; Achim Heinecke
Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects.
Seminars in oncology 1997;24(1):124-31.
1997: Torsten Liersch; Bernhard Wörmann; HF Rauschecker; Cornelia C Kaufmann; Wolfgang Hiddemann; Heinz Becker; W Gatzemeier
[Brief interdisciplinary oncology: a model for ambulatory, multimodal treatment of tumor patients].
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 1997;114():607-9.
1997: Gerald G Wulf; B Jürgens; Torsten Liersch; W Gatzemeier; HF Rauschecker; Christian Buske; Michael Hüfner; Wolfgang Hiddemann; Bernhard Wörmann
Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
Journal of cancer research and clinical oncology 1997;123(9):514-21.
1997: B Gahn; C Schäfer; J Neef; C Troff; Michaela Feuring-Buske; Wolfgang Hiddemann; Bernhard Wörmann
Detection of trisomy 12 in CD34+ progenitor cells in a patient with B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 2():55-7.
1997: Wolfgang Kern; Eberhard Schleyer; Michael Unterhalt; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias. Results of a clinical phase II study.
Cancer 1997;79(1):59-68.
1996: Gerald G Wulf; G Jahns-Streubel; Frank Strutz; D Basenau; M Hüfner; Christian Buske; Bernhard Wörmann; Wolfgang Hiddemann
Paraneoplastic hypokalemia in acute myeloid leukemia: a case of renin activity in AML blast cells.
Annals of hematology 1996;73(3):139-41.
1996: B Gahn; Detlef Haase; Michael Unterhalt; M Drescher; Claudia Schoch; Christa Fonatsch; L W Terstappen; Wolfgang Hiddemann; Thomas Büchner; J M Bennett; Bernhard Wörmann
De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.
Leukemia 1996;10(6):946-51.
1996: Wolfgang Hiddemann; Michael Unterhalt; Bernhard Wörmann
[Therapy of low-grade non-Hodgkin lymphomas].
Praxis 1996;85(12):357-63.
1996: Gerald G Wulf; G Edel; B Deneke; U Gottschalk; Wolfgang Hiddemann; Bernhard Wörmann
A cell-surface epitope associated with liver-preferential metastasis detected by the new monoclonal antibody 3H4 in the murine tumor model ER 15-P.
Journal of cancer research and clinical oncology 1996;122(8):476-82.
1995: G Jahns-Streubel; C Reuter; Michael Unterhalt; Eberhard Schleyer; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemia.
Leukemia 1995;9(11):1857-63.
1995: Detlef Haase; Michaela Feuring-Buske; S Könemann; Christa Fonatsch; C Troff; Walter Verbeek; Arnulf Pekrun; Wolfgang Hiddemann; Bernhard Wörmann
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.
Blood 1995;86(8):2906-12.
1995: Walter Verbeek; A Pies; Andreas Humpe; D Grove; C Troff; E Kunze; Wolfgang Hiddemann; Bernhard Wörmann
Mobilization of CD34-positive tumour cells in a patient with testicular mixed germ cell tumour.
British journal of haematology 1995;90(4):947-50.
1995: Michaela Feuring-Buske; Detlef Haase; S Könemann; C Troff; D Grove; Wolfgang Hiddemann; Bernhard Wörmann
Trisomy 4 in 'stem cell-like' leukemic cells of a patient with AML.
Leukemia 1995;9(8):1318-20.
1995: H Rieder; Susanne Schnittger; H Bodenstein; M Schwonzen; Bernhard Wörmann; D Berkovic; Wolf-Dieter Ludwig; D Hoelzer; Christa Fonatsch
dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia.
Genes, chromosomes & cancer 1995;13(1):54-61.
1995: Detlef Haase; Christa Fonatsch; Mathias Freund; Bernhard Wörmann; H Bodenstein; H Bartels; B Stollmann-Gibbels; E Lengfelder
Cytogenetic findings in 179 patients with myelodysplastic syndromes.
Annals of hematology 1995;70(4):171-87.
1995: Walter Verbeek; Katalin Vehmeyer; Bernhard Wörmann; Wolfgang Hiddemann
The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Journal of cancer research and clinical oncology 1995;121(6):338-42.
1994: Bernhard Wörmann; C Reuter; Michael Zühlsdorf; Thomas Büchner; Wolfgang Hiddemann
Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia.
Seminars in oncology 1994;21(6 Suppl 16):39-43.
1994: Wolfgang Hiddemann; Bernhard Wörmann; C Reuter; Eberhard Schleyer; Michael Zühlsdorf; A Böckmann; Thomas Büchner
New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
Seminars in oncology 1994;21(6 Suppl 16):33-8.
1994: Christian Buske; Wolfgang Hiddemann; Bernhard Wörmann
Proliferation of human leukemic pre-B cells induced by human bone marrow stromal cells and murine fibroblasts.
Cell biology international 1994;18(11):1049-58.
1994: C Reuter; U Auf der Landwehr; Eberhard Schleyer; Michael Zühlsdorf; C Ameling; C Rolf; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Leukemia 1994;8(2):217-25.
1993: Wolfgang Hiddemann; Michael Unterhalt; Christiane Pott; Bernhard Wörmann; D Sandford; Mathias Freund; A Engert; W Gassmann; W Holtkamp; J Seufert
Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
Seminars in oncology 1993;20(5 Suppl 7):28-31.
1993: Bernhard Wörmann
[Myelodysplastic syndrome and secondary leukemia].
Der Internist 1993;34(6):518-25.
1993: Bernhard Wörmann; M Unterhalt; W Hiddemann
[Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma].
Der Internist 1993;34(2):132-8.
1993: Bernhard Wörmann
Implications of detection of minimal residual disease.
Current opinion in oncology 1993;5(1):3-12.
1993: Bernhard Wörmann; M Safford; S Könemann; Thomas Büchner; Wolfgang Hiddemann; L W Terstappen
Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():185-96.
1993: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; R Rottmann; Georg Maschmeyer; Wolf-Dieter Ludwig; Michael Zühlsdorf; K Buntkirchen; A Sander; J Aswald
The role of GM-CSF in the treatment of acute myeloid leukemia.
Leukemia & lymphoma 1993;11 Suppl 2():21-4.
1992: Wolfgang Hiddemann; Eberhard Schleyer; Michael Unterhalt; Michael Zühlsdorf; C Rolf; C Reuter; U Kewer; C Uhrmeister; Bernhard Wörmann; Thomas Büchner
Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
Leukemia 1992;6(12):1273-80.
1992: G Behre; Ingolf Schedel; B Nentwig; Bernhard Wörmann; M Essink; Wolfgang Hiddemann
Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
Antimicrobial agents and chemotherapy 1992;36(10):2139-46.
1992: Wolfgang Hiddemann; Michael Kiehl; Michael Zühlsdorf; C Busemann; Eberhard Schleyer; Bernhard Wörmann; Thomas Büchner
Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Seminars in oncology 1992;19(2 Suppl 4):31-7.
1992: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Georg Maschmeyer; Dieter K Hossfeld; Wolf-Dieter Ludwig; M Nowrousian; Carlo Aul; U W Schaefer
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.
Leukemia 1992;6 Suppl 2():68-71.
1992: L W Terstappen; M Safford; S Könemann; M R Loken; K Zurlutter; Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann
Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.
Leukemia 1992;6(1):70-80.
1992: G Edel; A Roessner; B Deneke; Bernhard Wörmann
Morphological heterogeneity and phenotypical instability versus metastatic stability in the murine tumor model ER 15-P.
Journal of cancer research and clinical oncology 1992;118(5):349-60.
1991: Bernhard Wörmann; Wolfgang Hiddemann; J Frisch; Michael Zühlsdorf; R Rottmann; A Boeckmann; C Reuter; E A Freire; G Innig; G Schulz
In vitro and in vivo effects of rh GM-CSF in acute myeloid leukemia (AML).
Behring Institute Mitteilungen 1991;(90):28-38.
1991: Thomas Büchner; Wolfgang Hiddemann; Monika Koenigsmann; Michael Zühlsdorf; Bernhard Wörmann; A Boeckmann; E A Freire; G Innig; Georg Maschmeyer; Wolf-Dieter Ludwig
Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse.
Blood 1991;78(5):1190-7.
1991: Wolfgang Hiddemann; R Rottmann; Bernhard Wörmann; A Thiel; M Essink; C Ottensmeier; Mathias Freund; Thomas Büchner; Jürgen van de Loo
Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
Annals of hematology 1991;63(1):1-4.
1991: L W Terstappen; S Könemann; M Safford; M R Loken; K Zurlutter; Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann
Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
Leukemia 1991;5(4):315-21.
1990: Bernhard Wörmann; Jürgen van de Loo
[Fever, weight loss and rare paraneoplasias].
Der Internist 1990;31(8):532-7.
1990: Wolfgang Hiddemann; Michael Zühlsdorf; Bernhard Wörmann; Monika Koenigsmann; Thomas Büchner
Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy--a case report on the basis of a clinical phase II trial.
Leukemia research 1990;14(4):347-52.
1990: Wolfgang Hiddemann; Bernhard Wörmann; D Messerer; R Springefeld; Thomas Büchner
Analysis of the cellular DNA and RNA content in acute leukemias by flow cytometry.
Journal of cancer research and clinical oncology 1990;116(5):507-12.